Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy

Leuk Lymphoma. 2019 Nov;60(11):2806-2809. doi: 10.1080/10428194.2019.1605068. Epub 2019 May 6.

Affiliations

¹ Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
² Department of Clinical and Experimental Medicine, Hematology and Bone Marrow Transplant Unit, University of Verona, Verona, Italy.
³ Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

PMID: 31057013
DOI: 10.1080/10428194.2019.1605068

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antineoplastic Agents, Immunological / adverse effects*
Brentuximab Vedotin / adverse effects*
Female
Follow-Up Studies
Hodgkin Disease / drug therapy*
Hodgkin Disease / pathology
Humans
Lymphoma, Non-Hodgkin / drug therapy*
Lymphoma, Non-Hodgkin / pathology
Male
Middle Aged
Neoplasm Recurrence, Local / drug therapy*
Neoplasm Recurrence, Local / pathology
Peripheral Nervous System Diseases / etiology
Peripheral Nervous System Diseases / pathology*
Prognosis
Prospective Studies
Young Adult

Substances

Antineoplastic Agents, Immunological
Brentuximab Vedotin